The research activities at the Charles Drew University of Medicine and Science RCMI encompass the entire spectrum of research endeavors, from molecular biologists discovering genes which identify patients at increased risk for breast cancer, to clinical researchers studying advanced pharmacologic treatment of diabetes and hypertension, and epidemiologists assessing risk factors for blindness in diverse populations.
CDU has increasingly become recognized as a national and international leader in the performance of research and training of researchers focused on increasing the quality and number of years of healthy life and eliminating health disparities in minority and urban communities. The scope of our work also extends to emerging countries, all with a commitment to human compassion and academic excellence.
The following programs are representative a few of the key RCMI research focus areas in which the University has developed significant strengths and a pool of interested and talented investigators.
- Cancer Treatment and Diagnosis
- Cardiovascular Disease, Stroke and Hypertension
- Children’s Health Issues
- Clinical Trials
- Gender Issues in Health and Disease
- Neuropsychiatric Disorders
- Preventive Medicine and Health Promotion
- Substance Abuse
Selected RCMI Research Activities
- Effect of Dietary Salt on Melanocortin Receptor Expression in Spontaneously Hypertensive Rat Kidneys; Primary Investigator - Gangadarshni Chandramohan, MD
- Empowerment Evaluation of the Project Export/Community Diabetes Initiative; Primary Investigator - Keisha Paxton, PhD
- Early Nephropathy Study in Diabetes with Inhibitory Renin-Angiotensin-Aldosterone System Therapy (END-IT); Primary Investigator - Naureen Tareen, MD
- Dose Response Effects of Aerobic Exercise on Insulin Sensitivity and the Metabolic Syndrome; Primary Investigator - Stanley Hsia, MD
- The Assessment of Depressive Symptoms in African-American and Hispanic Women; Primary Investigator - Diana Echeverry, MD
- Keloids: Epidemiologic and Genetic Studies; Primary Investigator - A. Paul Kelly, MD
- Effects of Testosterone Replacement in Men with Erectile Dysfunction and Low Testosterone Levels Who Are Receiving a Selective Phosphodiesterase; Primary Investigator - Atambir Singh, MD